Table 1.
Peptide used to stimulate murine splenocytes* | Cytokine responses raised in mice after immunization with RT genes | |||||
---|---|---|---|---|---|---|
RTwt-opt-in | RT1.14-opt-in | |||||
IFN-γ | IL-2 | IFN-γ/IL-2 | IFN-γ | IL-2 | IFN-γ/IL-2 | |
RT 199–216 wt | >100 | 50–100 | 50–100 | <50 | <50 | <50 |
RT 199–216 dr | >100 | >100 | >100 | <50 | <50 | <50 |
RT 202–210 wt | <50 | <50 | <50 | <50 | <50 | <50 |
RT 202–210 dr | <50 | <50 | <50 | <50 | <50 | <50 |
RT 205–220 wt | >100 | >100 | >100 | <50 | <50 | <50 |
RT 205–220 dr | >100 | >100 | >100 | <50 | <50 | <50 |
RT 207–215 wt | 50–100 | <50 | <50 | <50 | <50 | <50 |
RT 207–215 dr | 50–100 | 50–100 | <50 | <50 | <50 | <50 |
Each entry represents the results of two or more IFN-γ/IL-2 Fluorospot tests performed after single or repeated (double-prime and prime-boost) RT gene immunizations: >100 – more than 100, 50–100–50 to 100, <50 - less than 50 spot-forming cells per million stimulated lymphocytes (splenocytes). *Peptide sequences are given in Table 1. Results of Fluorospot tests that are discordant with the results of the multi-parametric FACS assays (Fig. 9) are in bold type. For the description of the immunization experiment, see “Materials and methods” and legends to Figs 2 and 3.